Integrated BioPharma (OTCPK:INBP) - Stock Price, News & Analysis

INBP Stock Overview

Engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. More details

INBP fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	2/6
Financial Health	6/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (20.3x) is below the Personal Products industry average (26.5x)

Became profitable this year

Risk Analysis

Earnings have declined by 30.4% per year over past 5 years

Highly volatile share price over the past 3 months compared to the US market

Does not have a meaningful market cap ($10M)

Integrated BioPharma, Inc. Competitors

United-Guardian

NasdaqGM:UG

US$43.9m

Synergy CHC

NasdaqGM:SNYR

US$55.4m

Natural Health Trends

NasdaqCM:NHTC

US$65.4m

AXIL Brands

NYSEAM:AXIL

US$25.1m

Price History & Performance

Summary of all time highs, changes and price drops for Integrated BioPharma
Historical stock prices
Current Share Price	US$0.29
52 Week High	US$0.35
52 Week Low	US$0.16
Beta	0.62
11 Month Change	20.61%
3 Month Change	45.00%
1 Year Change	23.40%
33 Year Change	-69.47%
5 Year Change	13.73%
Change since IPO	-95.17%

Recent updates

Shareholder Returns

	INBP	US Personal Products	US Market
7D	-12.0%	-0.5%	-2.1%
1Y	23.4%	-14.2%	29.6%

Return vs Industry: INBP exceeded the US Personal Products industry which returned -14.2% over the past year.

Return vs Market: INBP underperformed the US Market which returned 29.6% over the past year.

Price Volatility

Is INBP's price volatile compared to industry and market?
INBP volatility
INBP Average Weekly Movement	17.9%
Personal Products Industry Average Movement	8.4%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.5%
10% least volatile stocks in US Market	3.1%

Stable Share Price: INBP's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine INBP's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1980	147	Riva Sheppard	ir.ibiopharma.com

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through two segments, Contract Manufacturing and Other Nutraceutical Businesses. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.

Integrated BioPharma, Inc. Fundamentals Summary

How do Integrated BioPharma's earnings and revenue compare to its market cap?
INBP fundamental statistics
Market cap	US$10.23m
Earnings (TTM)	US$430.00k
Revenue (TTM)	US$51.02m

20.3x

P/E Ratio

0.2x

P/S Ratio

Is INBP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
INBP income statement (TTM)
Revenue	US$51.02m
Cost of Revenue	US$46.60m
Gross Profit	US$4.42m
Other Expenses	US$3.99m
Earnings	US$430.00k

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.014
Gross Margin	8.67%
Net Profit Margin	0.84%
Debt/Equity Ratio	0%

How did INBP perform over the long term?

See historical performance and comparison

Integrated BioPharma OTCPK:INBP Stock Report